Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Initiates Coverage On Olema Pharmaceuticals with Neutral Rating

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Neutral rating.

byBenzinga Newsdesk

February 28, 2022

1 minute read

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Neutral rating.

News

Fluidigm Announces $250M Capital Infusion From Casdin Capital And Viking Global Investors And Rebranding To Standard BioTools Inc.

By Bill Haddad

Today, 2:46 PM

Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions Dr. Michael Egholm, Former CTO of Danaher Life Sciences, to

FLDM

HC Wainwright & Co. Maintains Buy on Sigma Labs, Lowers Price Target to $4

By Benzinga Newsdesk

Today, 2:46 PM

HC Wainwright & Co. analyst Scott Buck maintains Sigma Labs (NASDAQ:SGLB) with a Buy and lowers the price target from $6 to $4.

SGLB

BMO Capital Maintains Market Perform on GrafTech International, Raises Price Target to $6

By Benzinga Newsdesk

Today, 2:46 PM

BMO Capital analyst David Gagliano maintains GrafTech International (NYSE:EAF) with a Market Perform and raises the price target from $5 to $6.

EAF

Wheels Up Stock Slides On Q3 Loss, Margin Pressure

By Akanksha

Today, 2:46 PM

Wheels Up Experience Inc (NYSE:UP) reported a third-quarter revenue increase of 55% year-over-year to $301.98 million. The company’s Active Members grew…

HC Wainwright & Co. Initiates Coverage On Olema Pharmaceuticals with Neutral Rating

Related Posts

Fluidigm Announces $250M Capital Infusion From Casdin Capital And Viking Global Investors And Rebranding To Standard BioTools Inc.

HC Wainwright & Co. Maintains Buy on Sigma Labs, Lowers Price Target to $4

BMO Capital Maintains Market Perform on GrafTech International, Raises Price Target to $6

Wheels Up Stock Slides On Q3 Loss, Margin Pressure